Table 2 Hazard ratio for mortality based on quartile of GPR.

From: Associations of serum glucose/potassium ratio with short-term and long-term mortality in sepsis patients: a retrospective cohort study based on the MIMIC-IV database

Categories

Model 1

HR (95%CI)

P-value

Model 2

HR (95%CI)

P-value

Model 3

HR (95%CI)

P-value

30-days ACM

      

continues variable

perunit

1.220 (1.188–1.252)

< 0.001

1.217 (1.186–1.249)

< 0.001

1.128 (1.097–1.159)

< 0.001

Quartile

      

Q1

Reference

 

Reference

 

Reference

 

Q2

0.736 (0.687–0.789)

< 0.001

0.744 (0.694–0.797)

< 0.001

0.889 (0.828–0.955)

< 0.001

Q3

0.921 (0.862–0.983)

0.014

0.915 (0.857–0.978)

0.008

1.080 (1.007–1.159)

0.031

Q4

1.262 (1.187–1.342)

< 0.001

1.245 (1.170–1.324)

< 0.001

1.262 (1.173–1.358)

< 0.001

P for trend

< 0.001

 

< 0.001

 

< 0.001

 

90-days ACM

      

continues variable

perunit

1.191 (1.163–1.219)

< 0.001

1.192 (1.163–1.221)

< 0.001

1.116 (1.088–1.145)

< 0.001

Quartile

      

Q1

Reference

 

Reference

 

Reference

 

Q2

0.764 (0.719–0.812)

< 0.001

0.773 (0.728–0.821)

< 0.001

0.900 (0.846–0.958)

< 0.001

Q3

0.938 (0.885–0.994)

0.03

0.936 (0.884–0.992)

0.025

1.063 (1.00-1.131)

0.052

Q4

1.228 (1.162–1.297)

< 0.001

1.219 (1.154–1.288)

< 0.001

1.209 (1.133–1.290)

< 0.001

P for trend

< 0.001

 

< 0.001

 

< 0.001

 

180-days ACM

      

continues variable

perunit

1.172 (1.146–1.199)

< 0.001

1.174 (1.147–1.201)

< 0.001

1.108 (1.081–1.136)

< 0.001

Quartile

      

Q1

Reference

 

Reference

 

Reference

 

Q2

0.780 (0.737–0.825)

< 0.001

0.791 (0.747–0.837)

< 0.001

0.911 (0.859–0.965)

0.002

Q3

0.947 (0.897-1.000)

0.051

0.947 (0.897-1.000)

0.05

1.060 (1.001–1.124)

0.048

Q4

1.220 (1.158–1.284)

< 0.001

1.214 (1.152–1.279)

< 0.001

1.200 (1.129–1.275)

< 0.001

P for trend

< 0.001

 

< 0.001

 

< 0.001

 

1 year ACM

      

continues variable

perunit

1.158 (1.133–1.183)

< 0.001

1.160 (1.135–1.186)

< 0.001

1.101 (1.075–1.128)

< 0.001

Quartile

      

Q1

Reference

 

Reference

 

Reference

 

Q2

0.795 (0.754–0.837)

< 0.001

0.806 (0.765–0.850)

< 0.001

0.917 (0.869–0.968)

0.002

Q3

0.953 (0.906–1.003)

0.064

0.955 (0.908–1.005)

0.076

1.051 (0.996–1.110)

0.071

Q4

1.204 (1.147–1.265)

< 0.001

1.202 (1.144–1.262)

< 0.001

1.173 (1.107–1.242)

< 0.001

P for trend

< 0.001

 

< 0.001

 

< 0.001

 
  1. Model 1: unadjusted;.
  2. Model 2: adjusted for age, gender, and race;.
  3. Model 3: adjusted for age, gender, race, acute physiology and chronic health score, blood urea nitrogen, serum calcium, charlson comorbidity index, serum creatinine, glasgow coma scale, blood pressure, respiration, heart rate, temperature, blood oxygen saturation, lactate, mean corpuscular volume, oxford acute illness severity score, platelets, serum potassium, partial thromboplastin time, red cell distribution width, systemic inflammatory response syndrome, white blood cells, acute renal failure, ampicillin sodium sulbactam sodium, acute respiratory distress syndrome, atrial fibrillation, chronic liver disease, chronic obstructive pulmonary disease, continuous renal replacement therapy, diabetes mellitus, dopamine, fluconazole, heart failure, heparin sodium, human albumin, hydrocortisone, hypertension, insulin, mechanical ventilation, meropenem, myocardial infarction, norepinephrine, peripheral vascular disease, piperacillin-tazobactam sodium, renal failure, septic shock, and vancomycin.
Back to article page